International Stem Cell CORP (ISCO) Form 8-K Material Events
International Stem Cell CORP (ISCO) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ISCO
CIK: 1355790
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerBo-Reum Monaco
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-17 | 2026-09-16 | 4 Filing | 0001683168-26-007223 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | 4 Filing | 0001683168-26-007164 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001949846-26-000580 | View SEC Doc Filr Page |
| 8-K | 2026-09-08 | 2026-09-01 | FORM 8-K | 0001683168-26-007007 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349108 | View SEC Doc Filr Page |
| DEF 14C | 2026-08-04 | 2026-08-04 | DEFINITIVE INFORMATION STATEMENT | 0001683168-26-005946 | View SEC Doc Filr Page |
| PRE 14C | 2026-07-24 | 2026-07-24 | PRELIMINARY INFORMATION STATEMENT | 0001683168-26-005767 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-10 | CURRENT REPORT | 0001683168-26-005555 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-11 | 4 Filing | 0001683168-26-005075 | View SEC Doc Filr Page |
| 4 | 2026-06-23 | 2026-06-11 | 4 Filing | 0001683168-26-005073 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | CURRENT REPORT | 0001683168-26-004786 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | 10-Q | 0001193125-26-223926 | View SEC Doc Filr Page |
| ARS | 2026-04-29 | 2025-12-31 | ARS | 0001193125-26-191950 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-29 | 2026-06-11 | DEF 14A | 0001193125-26-191906 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | 10-K | 0001193125-26-131723 | View SEC Doc Filr Page |
| 8-K | 2025-11-18 | 2025-06-17 | CURRENT REPORT | 0001683168-25-008521 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001193125-25-280090 | View SEC Doc Filr Page |
| 8-K | 2025-09-16 | 2025-09-15 | CURRENT REPORT | 0001683168-25-007018 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | 10-Q | 0001193125-25-180761 | View SEC Doc Filr Page |
| 4 | 2025-06-20 | 2025-06-17 | 4 Filing | 0001683168-25-004622 | View SEC Doc Filr Page |
| 4 | 2025-06-20 | 2025-06-17 | 4 Filing | 0001683168-25-004620 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | 10-Q | 0000950170-25-071338 | View SEC Doc Filr Page |
| ARS | 2025-04-24 | 2024-12-31 | ARS | 0000950170-25-058122 | View SEC Doc Filr Page |
| DEF 14A | 2025-04-24 | 2025-06-17 | DEF 14A | 0000950170-25-058111 | View SEC Doc Filr Page |
| 10-K | 2025-03-28 | 2024-12-31 | 10-K | 0000950170-25-046745 | View SEC Doc Filr Page |